Change: -2.34 %Chge: -1.80% Vol: 693,160
Johnson & Johnson Company Profile
Johnson & Johnson (JNJ) is a large cap multinational corporation trading on NYSE, part of the health care sector. The company is divided into three major divisions: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson (JNJ) manages 250 operating companies and franchises in 60 countries and is the second largest manufacturer of health care products. This company owns the Tylenol, Band-Aid and Neutrogena brands. Employing 115,500 people, the largest
» Read More About Johnson & Johnson
JNJ Chart
You need Flash Player to see the chart, please download from the link below
Related Healthcare and Pharmaceuticals Companies
| Biogen Idec |
113.44
|
292,019 |
| Steris |
32.19
|
180,900 |
| Davita |
120
|
76,182 |
| Life Technologies |
6.23
|
9,159 |
| Bio Rad Labs |
124.09
|
5,311 |
| Endo Pharmaceuticals Hldgs |
36.05
|
505,430 |
| Tenet Healthcare |
56.62
|
154,077 |
| Illumina |
185.945
|
39,853 |
Above is a small selection of related companies to Johnson & Johnson which compete alongside JNJ within the Healthcare and Pharmaceuticals sector. To see more related companies to JNJ, view our stock market today information page.
Online News For Johnson & Johnson
Why Johnson & Johnson’s (NYSE:JNJ) ROE Of 2.16% Does Not Tell The Whole Story
Johnson & Johnson (NYSE:JNJ) delivered a less impressive 2.16% ROE over the past year, compared to the 10.88% return generated by its industry. Though JNJ’s recent performance is underwhelming, it is useful to understand what ROE is made up of and how it ...
J&J (JNJ) Beats on Q1 Earnings & Sales, Ups 2018 Sales View
Johnson & Johnson (JNJ - Free Report) , the bellwether of healthcare companies, has a strong presence in the pharmaceutical, medical devices and consumer care markets across the world. This New Jersey-based company is well known for its baby-care products ...
Excalibur Management Corp Trims Stake in Johnson & Johnson (NYSE:JNJ)
35 investors sold all, 884 reduced holdings as JNJ ratio improved. 143 funds opened positions while 654 raised stakes. Eqis Capital holds 0.2% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 27,787 shares. The healthcare conglomerate, whose stock had ...
J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance
Johnson & Johnson (JNJ - Free Report) kicked off 2018 pharma earnings on a strong note, beating the Zacks Consensus Estimate on both counts in the first quarter of 2018. The drug and consumer products giant upped its previously issued sales outlook for 2018.
Johnson & Johnson (JNJ) Stake Raised by APG Asset Management NV
The stock underperformed the S&P 500 by 10.43%. Koch Industries Inc increased its stake in New York Cmnty Bancorp Inc (NYCB) by 471.94% based on its latest 2017Q4 regulatory filing with the SEC. Regal Investment Advisors Llc bought 7,137 shares as the ...
Want To Add This Quote To Your Site?
With our stock widgets you can add a Johnson & Johnson quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for JNJ to choose from. Visit here to build your stock quote widget »
